Colloid and Polymer Science

, Volume 288, Issue 9, pp 1019–1026 | Cite as

Preparation of poly(butylcyanoacrylate) drug carriers by nanoprecipitation using a pre-synthesized polymer and different colloidal stabilizers

  • Georgi G. Yordanov
  • Ceco D. Dushkin
Short Communication


Classically, drug-loaded poly(alkylcyanoacrylate) colloidal carriers are prepared by the drug entrapment during emulsion polymerization. However, a number of chemically sensitive drugs are unstable in the conditions of polymerization or can be irreversibly inactivated by the highly reactive monomer. Furthermore, the particle size distribution and the molecular weight of formed polymer depend strongly on the polymerization conditions. Here, we investigate the nanoprecipitation approach for the preparation of pure and drug-load poly(butylcyanoacrylate) nanoparticles. This method allows the successful entrapment of lipophilic and chemically labile drugs by avoiding the contact with highly reactive monomers. The anticancer agent chlorambucil is chosen as the model drug for the incorporation and release studies. Pure and drug-loaded nanoparticles are successfully prepared using various stabilizers (Polysorbate 80, Pluronic F68, Dextran 40). The nanoparticles coated with Polysorbate 80 are of highest interest since they could overcome the blood–brain barrier and the multidrug resistance in cancer cells. Such nanoparticles can be easily prepared by the nanoprecipitation approach reported here.


Poly(butylcyanoacrylate) Nanoparticles Nanoprecipitation Chlorambucil Pluronic F68 Polysorbate 80 Dextran 40 



The authors are thankful to COST Action D43 of the European Community.


  1. 1.
    Vauthier C, Dubernet C, Fattal E, Pinto-Alphandary H, Couvreur P (2003) Adv Drug Deliv Rev 55:519–548CrossRefGoogle Scholar
  2. 2.
    Garcia-Garcia E, Andrieux K, Gil S, Couvreur P (2005) Int J Pharm 298:274–292CrossRefGoogle Scholar
  3. 3.
    Vauthier C, Labarre D, Ponchel G (2007) J Drug Target 15:641–663CrossRefGoogle Scholar
  4. 4.
    Oowaki H, Matsuda S, Sakai N, Ohta T, Iwata H, Sadato A, Taki W, Hashimoto N, Ikada Y (2000) Biomaterials 21:1039–1046CrossRefGoogle Scholar
  5. 5.
    Murthy R, Reddy L (2006) Poly(Alkyl Cyanoacrylate) nanoparticles for delivery of anti-cancer drugs. In: Amiji MM (ed) Nanotechnology for cancer therapy. CRC, Boca Raton, pp 251–288Google Scholar
  6. 6.
    Arias J, Ruiz A, Lopez-Viota M, Delgado A (2008) Colloid Surface B 62:64–70CrossRefGoogle Scholar
  7. 7.
    Petri B, Bootz A, Khalansky A, Hekmatara T, Müller R, Uhl R, Kreuter J, Gelperina S (2007) J Control Release 117:51–58CrossRefGoogle Scholar
  8. 8.
    Kreuter J, Alyautdin R, Kharkevich D, Ivanov A (1995) Brain Res 674:171–174CrossRefGoogle Scholar
  9. 9.
    Arias J, Gallardo V, Ruiz A, Delgado A (2008) Eur J Pharm Biopharm 69:54–63CrossRefGoogle Scholar
  10. 10.
    Gulyaev A, Ermekbaeva B, Kivman G, Radchenko T, Sherstov A, Shirinskii V (1998) Pharm Chem J 32:3Google Scholar
  11. 11.
    Pinto-Alphandary H, Andremont A, Couvreur P (2000) Int J Antimicrob Ag 13:155–168CrossRefGoogle Scholar
  12. 12.
    Fattal E, Youssef M, Couvreur P, Andremont A (1989) Antimicrob Agents Chemother 33:1540–1543Google Scholar
  13. 13.
    Kisich K, Gelperina S, Higgins M, Wilson S, Shipulo E, Oganesyan E, Heifets L (2007) Int J Pharm 345:154–162CrossRefGoogle Scholar
  14. 14.
    Fontana G, Licciardi M, Mansueto S, Schillaci D, Giammona G (2001) Biomaterials 22:2857–2865CrossRefGoogle Scholar
  15. 15.
    Cavallaro G, Fresta M, Giammona G, Puglisi G, Villari A (1994) Int J Pharm 111:31–41CrossRefGoogle Scholar
  16. 16.
    Zhang Q, Shen Z, Nagai T (2001) Int J Pharm 218:75–80CrossRefGoogle Scholar
  17. 17.
    Graf A, Jack K, Whittaker A, Hook S, Rades T (2008) Eur J Pharm Sci 33:434–444CrossRefGoogle Scholar
  18. 18.
    Lambert G, Fattal E, Pinto-Alphandary H, Gulik A, Couvreur P (2000) Pharm Res 17(6):707–714CrossRefGoogle Scholar
  19. 19.
    Briesen H, Ramge P, Kreuter J (2000) AIDS Rev 2:31–38Google Scholar
  20. 20.
    Kuo Y (2005) Int J Pharm 290:161–172CrossRefGoogle Scholar
  21. 21.
    Couvreur P, Kante B, Roland M, Guiot P, Bauduin P, Speiser P (1979) J Pharm Pharmacol 31:331–332Google Scholar
  22. 22.
    Douglas SJ, Illum L, Davis SS, Kreuter J (1984) J Colloid Interface Sci 101:149–158CrossRefGoogle Scholar
  23. 23.
    Douglas SJ, Illum L, Davis SS (1985) J Colloid Interface Sci 103:154–163CrossRefGoogle Scholar
  24. 24.
    Vansnick L, Couvreur P, Christiaensleyh D, Roland M (1985) Pharm Res 1:36–41CrossRefGoogle Scholar
  25. 25.
    El-Egakey MA, Bentele V, Kreuter J (1983) Int J Pharm 13:349–352CrossRefGoogle Scholar
  26. 26.
    Lescure F, Zimmer C, Roy D, Couvreur P (1992) J Colloid Interface Sci 154:77–86CrossRefGoogle Scholar
  27. 27.
    Douglas SJ, Davis SS, Holding SR (1985) Br Polym J 17:339–342CrossRefGoogle Scholar
  28. 28.
    Alonso MJ, Sanchez A, Torres D, Seijo B, Vila-Jato JL (1990) J Microencapsul 7:517–526CrossRefGoogle Scholar
  29. 29.
    Guise V, Drouin JY, Benoit J, Mahuteau J, Dumont P, Couvreur P (1990) Pharm Res 7:736–741CrossRefGoogle Scholar
  30. 30.
    Grangier JL, Puygrenier M, Gautier JC, Couvreur P (1991) J Control Release 15:3–13CrossRefGoogle Scholar
  31. 31.
    Page-Clisson ME, Pinto-Alphandary H, Ourevitch M, Andremont A, Couvreur P (1998) J Control Release 56:23–32CrossRefGoogle Scholar
  32. 32.
    Thioune O, Fessi H, Devissaguet JP, Puisieux F (1997) Int J Pharm 146:233–238CrossRefGoogle Scholar
  33. 33.
    Ganachaud F, Katz JL (2005) Chem Phys Chem 6:209–216Google Scholar
  34. 34.
    Stella B, Arpicco S, Peracchia MT, Desmaele D, Hoebeke J, Renoir M, D’Angelo J, Cattel L, Couvreur P (2000) J Pharm Sci 89:1452–1464CrossRefGoogle Scholar
  35. 35.
    Li YP, Pei YY, Zhou ZH, Zhang XY, Gu ZH, Ding J, Zhou JJ, Gao XJ, Zhu JH (2001) Biol Pharm Bull 24:662–665CrossRefGoogle Scholar
  36. 36.
    Calvo P, Gouritin B, Brigger I, Lasmezas C, Deslys J, Williams A, Andreux JP, Dormont D, Couvreur P (2001) J Neurosci Methods 111:151–155CrossRefGoogle Scholar
  37. 37.
    Fernandez-Urrusuno R, Fattal E, Porquet D, Feger J, Couvreur P (1995) Toxicol Appl Pharmacol 130:272–279CrossRefGoogle Scholar
  38. 38.
    Vezin WR, Florence A (1980) J Biomed Mater Res 14:93–106CrossRefGoogle Scholar
  39. 39.
    Lenaerts V, Couvreur P, Christiaens-Leyh D, Joiris E, Roland M, Rollman B, Speiser P (1984) Biomaterials 5:65–68CrossRefGoogle Scholar
  40. 40.
    Muller R, Lherm C, Herbort J, Couvreur P (1990) Biomaterials 11:590–595CrossRefGoogle Scholar
  41. 41.
    Treupel L, Poupon M, Couvreur P, Puisieux F (1991) CR Acad Sci III 313:171–174Google Scholar
  42. 42.
    Cuvier C, Roblot-Treupel L, Millot J, Lizard G, Chevillard S, Manfait M, Couvreur P, Poupon M (1992) Biochem Pharm 44:509–517CrossRefGoogle Scholar
  43. 43.
    Bennis S, Chapey C, Robert J, Couvreur P (1994) Eur J Cancer 30:89–93CrossRefGoogle Scholar
  44. 44.
    Kreuter J (2001) Adv Drug Deliv Rev 47:65–81CrossRefGoogle Scholar
  45. 45.
    Ramge P, Unger R, Oltrogge J, Zenker D, Begley D, Kreuter J, Briesen H (2000) Eur J Neurosci 12:1931–1940CrossRefGoogle Scholar
  46. 46.
    Gulyaev A, Gelperina S, Skidan I, Antropov A, Kivman G, Kreuter J (1999) Pharm Res 16:1564–1569CrossRefGoogle Scholar
  47. 47.
    Gelperina S, Khalansky A, Skidan I, Smirnova Z, Bobruskin A, Severin S, Turowski B, Zanella F, Kreuter J (2002) Toxicol Lett 126:131–141CrossRefGoogle Scholar
  48. 48.
    Hawley A, Davis S, Illum L (1995) Adv Drug Deliv Rev 17:129–148CrossRefGoogle Scholar
  49. 49.
    Moghimi S, Bonnemain B (1999) Adv Drug Deliv Rev 37:295–312CrossRefGoogle Scholar
  50. 50.
    Nishioka Y, Yoshino H (2001) Adv Drug Deliv Rev 47:55–64CrossRefGoogle Scholar
  51. 51.
    Oussoren C, Storm G (2001) Adv Drug Deliv Rev 50:143–156CrossRefGoogle Scholar
  52. 52.
    Hall A, Tilby M (1992) Blood Rev 6:163–173CrossRefGoogle Scholar
  53. 53.
    Ehrsson H, Eksborg S, Wallin I, Nilsson S (1980) J Pharm Sci 69:1091–1094CrossRefGoogle Scholar
  54. 54.
    Bosanquet A, Clarke H (1986) Cancer Chemoth Pharm 18:176–179CrossRefGoogle Scholar
  55. 55.
    Sharma P, Ganta S, Denny W, Garg S (2009) Int J Pharm 367:187–194CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  1. 1.Department of General and Inorganic Chemistry, Laboratory of Nanoparticle Science and Technology, Faculty of ChemistryUniversity of SofiaSofiaBulgaria

Personalised recommendations